NiSource Total Cost of Revenue increased by 39.0% to $669.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.4%, from $647.50M to $669.20M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 3.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $228.30M | $208.30M | $478.90M | $706.70M | $383.70M | $330.80M | $689.30M | $765.10M | $251.90M | $181.30M | $335.00M | $425.00M | $164.70M | $165.90M | $376.60M | $647.50M | $261.80M | $193.60M | $481.50M | $669.20M |
| QoQ Change | — | -8.8% | +129.9% | +47.6% | -45.7% | -13.8% | +108.4% | +11.0% | -67.1% | -28.0% | +84.8% | +26.9% | -61.2% | +0.7% | +127.0% | +71.9% | -59.6% | -26.1% | +148.7% | +39.0% |
| YoY Change | — | — | — | — | +68.1% | +58.8% | +43.9% | +8.3% | -34.3% | -45.2% | -51.4% | -44.5% | -34.6% | -8.5% | +12.4% | +52.4% | +59.0% | +16.7% | +27.9% | +3.4% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Columbia Operations | $379.80M | $110.40M | $58.50M | $271.10M | $383.90M |
| NIPSCO Operations | $267.70M | $151.40M | $135.20M | $210.40M | $285.30M |
| Total | $647.50M | $261.80M | $193.60M | $481.50M | $669.20M |